Formalization process - 5 days
Obtaining a product conformity certificate from the Fergana Region Certification Organization of the State Center for Expertise and Standardization of Medicines - 3 days ( Laboratory service - 500,000 soums )
Conclusion of the "Fergana expertise" enterprise on commodity codes - 1 day. (The fee for 1 brand name code is 3300 soums. 25 medicinal products are brought to the plan. The cost is 3300*25=82500 soums).
Declaration - 1 day (the amount of payment for the products of each producing country - 25,000 soums. According to the plan, the imported products will be produced in 3 countries. The cost of the declaration is 25,000*3=75,000 soums)
Customs inspection - 10 hours (Each hour - 5 euros. Cost - 50 euros. According to the state exchange rate
Customs clearance service - 0.2 % of the total value of the consignment .
Sales process and collection of money for conversion - 50 days
wholesales the products brought to the enterprises and medical institutions engaged in the sale of pharmaceutical products in the territory of our region and provides retail services to the population through its branches.
Imported medicinal products are sold with an 11% markup.
The table shows the price of the drugs imported from the Russian Federation according to the specification in freely exchangeable currency - US dollars and the amount for each position by the project initiator within 1 cycle.
The table of costs for purchased pharmaceutical products in 1 cycle (3 months) based on the full cycle of credit funds.
Table 4.
No
|
|
Measurement unit.
|
Number
|
Cost
USD.
|
Amount
USD.
|
1.
|
Analgin 50% 2ml amp. No. 10
|
Box
|
30000
|
0.303
|
9090
|
2.
|
Analgin 0.5 tab. No. 10
|
Box
|
300000
|
0.048
|
14400
|
3.
|
Acetylsalicylic acid 0.5 tab No. 10
|
Box
|
500000
|
0.032
|
16000
|
4.
|
Benzylpenicillin n/sol was 1 mln
|
Box
|
399892
|
0.081
|
32391,252
|
5.
|
Bralangin 5 ml amp. No. 5
|
Box
|
25000
|
0.926
|
23150
|
6.
|
Gentamicin sulfate 4% 2ml amp. No. 10
|
Box
|
20000
|
0.398
|
7960
|
7.
|
Geoxizon ointment 10g
|
Box
|
19999
|
0.464
|
9279,536
|
8.
|
Dimedrol 1ml amp. No. 10
|
Box
|
29998
|
0.155
|
4649.69
|
9.
|
Calcium gluconate 5ml amp. No. 10
|
Box
|
10000
|
1
|
10000
|
10.
|
Calcium chloride 10% 10ml amp. No. 10
|
Box
|
10000
|
0.588
|
5880
|
11.
|
Cocarboxylase 50ml amp. No. 5
|
Box
|
10000
|
0.588
|
5880
|
12.
|
Lactobacterin 5 doses
|
Box
|
9900
|
1,328
|
13147.2
|
13.
|
Levomekol 40g ointment
|
Box
|
20000
|
0.449
|
8980
|
14.
|
Levomycetin 0.5 tab#10
|
Box
|
100000
|
0.212
|
21200
|
15.
|
Lidase 64YeD
|
Box
|
14998
|
1,365
|
20472.27
|
16.
|
Magnesium sulfate 5 ml amp. #10
|
Box
|
20000
|
0.379
|
7580
|
17.
|
Novocaine 0.5% 5ml amp. #10
|
Box
|
500000
|
0.303
|
151500
|
18.
|
Piracetam 20% 5ml amp.#10
|
Box
|
20000
|
0.504
|
10800
|
19.
|
Riboxin 2% 10ml amp #10
|
Box
|
19910
|
0.797
|
15868.27
|
20.
|
Sinoflana 0.025% oil 10g tube
|
Box
|
8000
|
0.203
|
1624
|
21.
|
Sinoflana 0.025% oil 15g tube
|
Box
|
6000
|
0.286
|
1716
|
22.
|
Vitamin V-6 5% 1ml amp. No. 10
|
Box
|
8000
|
0.19
|
1520
|
23.
|
Vitamin V-12 500mcg 1ml amp. No. 10
|
Box
|
20000
|
0.265
|
5300
|
24.
|
Tetracycline 0.1 g
Tab. No. 20
|
Box
|
40000
|
0.117
|
4680
|
25.
|
Furazalidon 0.5
tab #10
|
Box
|
200000
|
0.026
|
5200
|
Depreciation Allowance
The private production enterprise "Medpharm" uses the building with the cadastral value of 50200000 soums in its balance sheet. " Tax in the code depreciation discount yearly quantity building and buildings in the amount of 5% for defined .
Depreciation deduction is 2510000 soums during the year. 627,500 soums per cycle (in 3 months).
Transportation table of expenses .
Table 4.2. (in soums)
T\r
|
Name of expenses
|
per month (soum)
|
In twelve months (soum)
|
1.
|
Transportation cost
|
10000
|
40000
|
|
Total:
|
10000
|
40000
|
During a full cycle of credit funds, for calculations in the implementation of activities, the amount of transport costs is 10,000 soums in one cycle. Basically, the cost of transportation from the wagon to the project initiator's warehouse (this distance is 5 km) is equal to 40,000 soums , taking into account the planned 4 cycles in 12 months.
Electricity costs
"Medpharm" private production company consumes 150 kW of electricity per month to light the warehouse and administrative building and meet other requirements. The initiator of the project will pay 33.4 soums per 1 kW. The cost of electricity in one month is 5010 soums, and in twelve months it is 60120 soums.
Organizational plan
the working hours at the private production enterprise "Medpharm" are 8 hours, and a working day is accepted as 6 days in a week.
List of states and labor compensation fund.
Table . 4.3.
No
|
List of states
|
Number
|
Oklad
(soum)
|
Monthly salary (soums)
|
Yearly to labor right to pay _ fund ( soum ) _ _ _ _
|
1.
|
Director
|
1
|
15000
|
15000
|
180000
|
2.
|
Accountant
|
1
|
13060
|
13060
|
156720
|
3.
|
Forwarder
|
1
|
13060
|
13060
|
156720
|
4.
|
Provisional
|
1
|
10000
|
10000
|
120000
|
|
Total
|
5
|
XXX
|
51120
|
613440
|
|
Social Security (31%)
|
|
|
15847.2
|
190166.4
|
|
Total salary fund
|
|
|
66967.2
|
803606,4
|
The labor compensation fund is 66,967.2 soums in 1 month and 803,606.4 soums in 12 months and is covered by the profit of the private production enterprise "Medpharm".
5. TAXES , FEES _ _ AND DISCOUNTS .
Medicine is medicine products trade with training _ _ was _ _ activity for entrepreneurship subjects _ _ gross income tax _ _ to pay _ defined . 2023 year for gross income tax _ _ rate the amount is 20% o ' is installed . " Medpharm " is private work release enterprise to the plan according to _ credit from funds _ used otherwise 12 months lifetime in , trade activity 444000000 soums from showing _ _ _ in the amount turnover bulishi , gross income quantity and 4,400,000 soums _ _ organize reach and gross from income payable _ _ tax amount is 8,800,000 soums _ organize is enough
Road _ _ fund ( gross from income - 1%), allowance fund - ( gross from income – 0.7%) and school fund ( gross from income - to 1%) . separable mandatory 12 months of payments inside planned 44000000 soums _ _ amount gross from income amount - 1,188,000 soums _ _ organize is enough
6. Financial plan _
"Medpharm" is private work release enterprise credit 10000000 soums from the account to funds _ removable and to the project adding _ _ own _ _ share with together purchase to be done medicine - medicine 11% discount on products the right sing _ _ to sell and three moon inside funds 1 time _ _ completely _ _ rotate planned _
As of April 2, 2023, the exchange rate of the Central Bank of Uzbekistan was 1100.26 soums against 1 US dollar. 100,000,000 soums of credit will be converted into freely exchangeable currency - 91721 US dollars.
the above indicators, table 6.1 shows the planned income from one full cycle of loan funds.
Table 6.
No
|
Name
|
Unit of measure
US dollars.
|
1 US dollar . Course in soum
|
Sumdai value
|
11% commission
|
Total income in 1 cycle (soums)
|
Total income for 4 cycles (soums)
|
1
|
Medicines
|
91721
|
1090.26
|
100000000
|
11000000
|
111,000,000
|
444,000,000
|
|
TOTAL
|
|
|
|
|
|
444,000,000
|
The expected gross income from the planned circulation of credit funds in one cycle is 111,000,000 soums, 444,000,000 soums in 4 cycles in twelve months.
10-11 months project initiator of credit main debt from the sum of 30,000,000 soums a total of 6,000,000 soums returns _ in the 12th month while of credit the remaining 40000000 soums _ main debt amount back to the plan according to _ bank in front of obligation closes _
12 months lifetime within 100000000 soums _ _ credit from funds _ 16 % of usage per year overtime quantity credit return - 14,763,000 so mni _ organize is enough
" Medpharm " is private work release enterprise 12 months during from the bank received 100,000,000 soums _ _ credit funds i _ from the account trade - sell done increasing credit _ funds i _ and percentages from return except 1986073.6 soums _ _ pure benefit takes _
CONCLUSION.
Before presenting this project, the initiator of the project thoroughly analyzed the situation in the market of medicinal products of Fergana city and Fergana region, taking into account all the factors affecting the implementation of the project.
The results of the cited financial indicators, as well as the analysis of the entire program of the organization of the sale of pharmaceutical products, the conditions in the domestic market, primarily the supply of pharmaceutical products, competition from similar enterprises, possible risks in the sales service and as a result of the analysis taking into account other factors, a conclusion is made about the effectiveness and vitality of all the activities indicated by the project initiator in the implementation of the project.
Implementation of this project will make it possible to implement the idea of the initiator of the project, as well as to add one's share to the economic reforms being carried out in our Republic.
Dostları ilə paylaş: |